Navigation Links
Sonic Innovations Celebrates 10-Year Anniversary
Date:4/20/2008

SALT LAKE CITY, April 2, 2008 /PRNewswire-FirstCall/ -- Sonic Innovations, Inc. (Nasdaq: SNCI) a U.S.-based manufacturer of digital hearing aids, is celebrating its 10-year anniversary during 2008.

The company is the largest publicly traded U.S.-based hearing aid manufacturer. More than half of the company's revenue is generated from outside the United States (company revenue for 2007 was $122 million).

"In just 10 years Sonic Innovations has leveraged its world class sound technology to become one of the largest hearing device manufacturers in the world. Sonic Innovations was among the first companies to implement digital technology into hearing aids and is a leader in digital-signal processing," noted Sonic Innovations CEO Sam Westover. "We continue to be a pioneer in our industry through continuous improvements in sound quality, by significantly decreasing the size of our hearing aids and through the development of new features that make our hearing devices simple to use and easily adaptable to the active lifestyle."

Sonic Innovations was founded upon sound technology from three internationally renowned scientists -- Douglas Chabries, Thomas Stockham Jr. and Carver Mead -- each with a Ph.D. in engineering. Chabries created algorithms that led to better speech-understanding in noise. Stockham, known as the "father of digital recording," developed mathematical methods that are used today in playing DVDs, processing Hubble space telescope images, improving medical images and creating better hearing aids. He is the only electrical engineering professor to be awarded a Grammy, an Emmy and an Academy Award. Mead is recognized as the father of large-scale integrated circuits. He has been involved in the start-up of over 20 different companies, including Intel.

In 1998, the company developed its first product, the Natura(R) hearing aid. (The name was derived from the fact that so many subjects in the field trials repeatedly said how natural the hearing aid sounded.) Natura(R) was one of the first digital hearing aids in the marketplace.

Westover noted that before the development of digital hearing aids, analog technology did not allow clinicians to maximize benefit for every patient's unique listening needs. In the simplest of terms, digital technology gives clinicians very fine frequency and volume adjustments, and access to tools that can control background noise while amplifying speech.

Since 1998, Sonic Innovations has developed several different digital product lines with a wide variety of features. Sonic Innovations will introduce two new hearing aids, representing a fourth generation of technological advancements, in April at the American Academy of Audiology Conference in Charlotte, N.C.

Sonic Innovations is headquartered in Salt Lake City, Utah, and has nearly 700 employees worldwide. Sonic distributes hearing aids in 25 countries, and has offices in Canada, Australia, Germany, Netherlands, Denmark, United Kingdom, Austria and Switzerland.

About Sonic Innovations

Sonic Innovations, Inc. is the largest, publicly traded U.S.-based hearing aid manufacturer. The company was founded with a mission to commercialize a unique digital signal processing platform for hearing aids. Sonic Innovations hearing aids were among the first of their kind clinically proven to increase speech understanding in noise for the hearing impaired. Sonic Innovations, headquartered in Salt Lake City, is listed on the NASDAQ Global Market System and can be found online at http://www.sonici.com.

This press release may contain "forward-looking statements" as defined under securities laws. Actual results may differ materially and adversely from those described herein depending on a number of factors including, but not limited to, the following risks: we face aggressive competition in our business; acquisitions could be difficult to integrate and disrupt our current business and therefore may harm our operating results; we may poorly operate newly acquired businesses; we may lose a large customer or suffer a reduction in orders from a large customer; we must have innovative, technologically superior products to compete effectively; our products, due to their complexity, may contain errors or defects that are only discovered after sales by our customers, thus harming our reputation and business; we may have issues with intellectual property; and we have important international operations, which expose us to a variety of risks including government reimbursement, that could impact sales and operating results. For additional information regarding the risks inherent in our business, please see "Factors That May Affect Future Performance" included in our Annual Report on Form 10-K for the year ended December 31, 2007, as filed with the Securities and Exchange Commission.

We undertake no obligation to revise our forward-looking statements to reflect events or circumstances after the date hereof as a result of new information, future events or otherwise.


'/>"/>
SOURCE Sonic Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology news :

1. OHSU turns innovations into commercial opportunities at record pace
2. Synaptics SecurePad(TM) Selected as CES Innovations 2008 Design and Engineering Award Honoree
3. NASA celebrates a decade observing climate impacts on health of worlds oceans
4. ESA celebrates 100 years of insect science journals
5. NASA celebrates a decade observing climate impacts on health of worlds oceans
6. Molecular Biology of the Cell celebrates 25 years of publication
7. Symposium marks 30th anniversary of discovery of third domain of life
8. ASNTR 15th anniversary meeting to be held May 1-3 in Florida
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2016)... MINNETONKA, Minn. , Jan. 20, 2016   ... that supports the entire spectrum of clinical research, is ... in 2015. MedNet,s significant achievements are the result of ... of) iMedNet eClinical , it,s comprehensive, ... --> --> Key MedNet growth ...
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
(Date:1/8/2016)... and MANCHESTER, United Kingdom , ... a developer of innovative sensor-based diagnostic products, today announced the ... by new and existing investors.  Proceeds from the financing will ... Scanner , a hand-held device for detecting early-stage pressure ulcers. ... Ireland after receiving CE Mark approval. The ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. ... the development and commercialization of targeted antiviral therapies, announced ... Investor Conference 2016, to be held February 8-9, 2016, ... Group,s 2016 Disruptive Growth & Healthcare Conference, taking place ... 10-11, 2016. James Sapirstein , Chief Executive ...
(Date:2/4/2016)... February 4, 2016 Strasbourg, France ... Inc. --> Strasbourg, France , to ... PharmaVentures is pleased to announce that it acted as ... manufacturing unit in Strasbourg, France , to ... --> --> Transgene (Euronext: TNG), a ...
(Date:2/3/2016)... 3, 2016  With the growing need for ... is underway, therapies such as monoclonal antibodies, recombinant ... host of indications are in high demand. Conventionally ... development and production of these therapeutics. However, due ... high costs, novel approaches and novel expression systems ...
(Date:2/3/2016)... ... February 03, 2016 , ... Aerocom, a world-leading supplier of ... North American healthcare market. , Aerocom Healthcare, LLC will be based in Denver, ... provide new pneumatic tube systems or expand existing systems within the U.S. and ...
Breaking Biology Technology: